Targeting ID2 reduced CRC growth in vivo and its expression was increased by WNT signalling under hypoxia35,36, and DAPK1 loss was linked to invasiveness of CRC cells37, supporting their roles in CRC pathogenesis. Here, ID2 is linked to colorectal carcinoma.